โ† Value Add PulseAI$965B valuation at risk

US Government Orders Anthropic to Suspend Claude Fable 5 and Mythos 5

Three days after launch, the US government invoked national security authorities to force-disable a live frontier model -- a regulatory first that no founder or investor had priced in. Anthropic's ~$965B valuation now carries sovereign risk.

TC
Trace Cohen
Early-stage VC & angel ยท Founder, New York Venture Partners
June 13, 2026
1 min read
KEY TAKEAWAYS FOR VCs & FOUNDERS
1

Every AI lab with an S-1 in the works just added a new risk factor section -- regulatory kill-switches are now a real threat

2

Boards everywhere are asking: what's our model-recall protocol if the government calls?

3

The precedent reshapes every frontier AI company's risk profile and could slow deployment timelines across the industry

TC
The VC Read ยท Trace's TakeTrace Cohen

This is the moment AI risk stopped being a panel topic and became an operating reality. A model that's live one day and dark the next changes how every founder should think about model dependency. If your product has a single-model point of failure, you just learned why multi-model routing isn't optional.

On June 13, the US government did something unprecedented: it ordered Anthropic to disable Claude Fable 5 and Mythos 5, its most capable frontier models, just three days after their public launch. The order was issued under national security authorities after a vulnerability was identified -- reportedly a simple prompt, not even a sophisticated jailbreak -- that produced outputs the government deemed unacceptable. Anthropic complied within hours, pulling both models from API access and consumer-facing products simultaneously.

This is the single most important regulatory event in AI since the executive order era began. It's not about Anthropic specifically -- it's about the precedent. The US government has now demonstrated a tested, operational playbook for forcing a private company to disable a live product used by millions of developers and enterprises. Every AI company with an S-1 in the works just added a new risk factor section. Every board of every frontier lab is now asking: what's our model-recall protocol? How fast can we comply? What's the revenue impact of a 72-hour shutdown?

โ€œEvery AI lab with an S-1 in the works just added a new risk factor section -- regulatory kill-switches are now a real threatโ€

The historical analog isn't tech regulation -- it's closer to pharmaceutical recalls. The FDA can pull drugs from market post-approval, and that authority reshapes how pharma companies price risk, structure insurance, and communicate with investors. AI just got its FDA moment. The difference is that drug recalls typically follow months of adverse event data; this happened in 72 hours based on a single capability demonstration. The speed of intervention is the real story -- it means regulators can move faster than companies can patch.

What to watch: Anthropic's confidential S-1 is already filed. The roadshow will now include pointed questions about regulatory risk that didn't exist two weeks ago. OpenAI, which has its own S-1 in process, is undoubtedly revising its risk disclosures. And every enterprise customer running Fable 5 in production just learned that their AI vendor's uptime is subject to government approval. Expect enterprise AI contracts to start including regulatory force majeure clauses by Q3.

Originally reported by Anthropic. Analysis and editorial commentary by Value Add Pulse.

โ† Back to Pulse